New hope for advanced prostate cancer: experimental drug AZD9750 enters human trials
NCT ID NCT07336446
First seen Jan 17, 2026 · Last updated May 25, 2026 · Updated 13 times
Summary
This study tests a new drug called AZD9750, alone or with another drug (saruparib), in people whose prostate cancer has spread to other parts of the body and is no longer controlled by standard treatments. The goal is to find the safest dose and see if it can shrink tumors or lower PSA levels. About 300 adults with metastatic prostate cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGDuarte, California, 91010, United States
-
Research Site
NOT_YET_RECRUITINGSan Francisco, California, 94143, United States
-
Research Site
NOT_YET_RECRUITINGTampa, Florida, 33612, United States
-
Research Site
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
-
Research Site
NOT_YET_RECRUITINGSt Louis, Missouri, 63108, United States
-
Research Site
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
Research Site
RECRUITINGNashville, Tennessee, 37203, United States
-
Research Site
NOT_YET_RECRUITINGSalt Lake City, Utah, 84112, United States
-
Research Site
RECRUITINGMelbourne, 3000, Australia
-
Research Site
NOT_YET_RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
Research Site
NOT_YET_RECRUITINGVancouver, British Columbia, V5Z 1H7, Canada
-
Research Site
NOT_YET_RECRUITINGChengdu, 610041, China
-
Research Site
NOT_YET_RECRUITINGChūōku, 104-0045, Japan
-
Research Site
RECRUITINGKashiwa, 227-8577, Japan
-
Research Site
NOT_YET_RECRUITINGAmsterdam, 1066CX, Netherlands
-
Research Site
NOT_YET_RECRUITINGRotterdam, 3015 GD, Netherlands
-
Research Site
NOT_YET_RECRUITINGBarcelona, 8035, Spain
-
Research Site
RECRUITINGCambridge, CB2 2QQ, United Kingdom
Conditions
Explore the condition pages connected to this study.